Vedanta Ltd has the best dividend yield in the last 12 months among large-cap stocks at 31 per ce...
Sanofi India is currently trading at Rs. 6117.00, up by 418.40 points or 7.34% from its previous ...
Weak Q4; power brands growth, future divestitures to be keenly watched… About the stock...
Strong earnings; NLEM uncertainties over Sanofi’s Q4CY22 revenue and PAT came above our ...
Q2 muted on high base of Covid and divestments… About the stock: Sanofi offers drugs in...
High costs suppress margins Sanofi India’s (SANL) Q2CY22 performance was below our estim...
Below estimates; focus remain on power brands Sanofi...
The company reported standalone net profit of Rs 120.40 crore for the quarter ended June 30, 2022...
Curtailed expenses lift margins Sanofi India’s (SANL) Q1CY22 performance was above our e...
The company reported standalone net profit of Rs 238.40 crore for the quarter ended March 31, 202...
Brand divestment impacts performance Sanofi India’s (SANL) Q4CY21 performance was below ...
Sanofi Q4CY21 concall highlights Sanofi India Limited (SANL) hosted an investor call to discus...
Domestic business (ex-divestment) grows at 13% in CY21 About the stock: Sanofi offers drugs in...
Sanofi India is currently trading at Rs. 7295.00, up by 17.55 points or 0.24% from its previous c...
Divestment of Nutraceuticals complete Rs8,069 Sanofi India’s (SANL) Q3CY21’s perfo...
Another quarter of controlled costs Sanofi India’s (SANL) Q2CY21’s performance was...
Decent performance with strong margins… About the stock: Sanofi offers drugs in the...
Controlled costs boosts margin Sanofi India’s (SANL) Q1CY21 performance was supported by...
Analyst call highlights Sanofi India Limited’s (SANL) is poised to grow owing to its hi...
Divestiture, Covid-19 impact sales; margins upbeat… CY20 revenues de-grew 5.5% YoY to |...
Weak quarter; sequential improvement Sanofi India’s (SANL) Q4CY20’s performance r...
The company reported standalone net profit of Rs 123.00 crore for the quarter ended D...
Buy Sanofi India Ltd For Target Rs.9,460 - HDFC Securities Our Take: Sanofi India ...